Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ETR/GXI stock hub

ETR/GXI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/GXIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

943.6M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/GXI

In the news

Latest news · ETR/GXI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10

P25 12.3P50 15.7P75 20.2

Trailing P/E40.4

P25 16.4P50 20.9P75 30.4

ROE1.8

P25 -6.7P50 8.5P75 17.2

ROIC3.1

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/GXI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

EUR

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	13,535
Employees Change	1,523%
Employees Change Percent	12.68
Enterprise value	EUR 3.1B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	DE000A0LD6E6
Last refreshed	2026-05-10
Market cap	EUR 943.6M
Price	EUR 27.32
Price currency	EUR
Rev Per Employee	166,255.19x
Sector	Healthcare
Sic	3220
Symbol	etr/GXI
Website	https://www.gerresheimer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.47%
EV Earnings	134.23x
EV/EBIT	20.31x
EV/EBITDA	7.77x
EV/FCF	-7.14x
EV/Sales	1.39x
FCF yield	-46.52%
Forward P/E	9.95x
P/B ratio	0.66x
P/E ratio	40.41x
P/S ratio	0.42x
PE Ratio10 Y	24.95x
PE Ratio3 Y	33.29x
PE Ratio5 Y	31.24x
PEG ratio	2.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.86%
EBITDA Margin	17.11%
Gross margin	26.89%
Gross Profit	EUR 605.2M
Gross Profit Growth	3.37%
Gross Profit Growth Q	-6.05%
Gross Profit Growth3 Y	5.32%
Gross Profit Growth5 Y	8.28%
Net Income	EUR 23.4M
Net Income Growth	-79.57%
Net Income Growth Years	0%
Net Income Growth3 Y	-36.35%
Pretax Margin	1.6%
Profit Margin	1.04%
Profit Per Employee	EUR 1,725
Profitable Years	18
ROA	2.34
Roa5y	3.74
ROCE	4.31
ROE	1.81
Roe5y	8.81
ROIC	3.11
Roic5y	5.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.25%
Cagr15y	0.06%
Cagr1y	-53.84%
Cagr3y	-34.15%
Cagr5y	-20.47%
Div CAGR10	-25.41%
Div CAGR3	-68.25%
Div CAGR5	-49.35%
EPS Growth	-79.57
EPS Growth Years	0
EPS Growth3 Y	-38.33
OCF Growth	-0.88%
OCF Growth Q	20.05%
OCF Growth10 Y	2.12%
OCF Growth3 Y	5.82%
OCF Growth5 Y	1.55%
Revenue Growth	11.83x
Revenue Growth Q	12.47x
Revenue Growth Quarters	18x
Revenue Growth Years	7x
Revenue Growth3 Y	9.28x
Revenue Growth5 Y	10.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.55
Assets	EUR 4.7B
Cash	EUR 145.9M
Current Assets	EUR 1.1B
Current Liabilities	EUR 1.1B
Debt	EUR 2.3B
Debt EBITDA	EUR 5.73
Debt Equity	EUR 1.62
Debt FCF	EUR -5.26
Equity	EUR 1.4B
Interest Coverage	1.44
Liabilities	EUR 3.3B
Long Term Assets	EUR 3.6B
Long Term Liabilities	EUR 2.2B
Net Cash	EUR -2.2B
Net Cash By Market Cap	EUR -229
Net Debt EBITDA	EUR 5.62
Net Debt Equity	EUR 1.52
Tangible Book Value	EUR -309.3M
Tangible Book Value Per Share	EUR -8.95
WACC	4.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.98
Inventory Turnover	3.73
Net Working Capital	EUR 440.3M
Quick ratio	0.41
Working Capital	EUR -18.8M
Working Capital Turnover	EUR -19.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%
Dividend Growth	-96.8%
Dividend Growth Years	0%
Dividend per share	EUR 0.04
Dividend Years	15
Dividend Yield	0.15%
Ex Div Date	2025-06-06
Last Dividend	EUR 0.04
Payout Frequency	Annual
Payout Ratio	0.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-52.88%
1Y total return	-53.81%
200-day SMA	29.07
3Y total return	-71.46%
50-day SMA	20.12
50-day SMA vs 200-day SMA	50under200
5Y total return	-68.17%
All Time High	122.9
All Time High Change	-77.77%
All Time High Date	2023-09-05
All Time Low	13.02
All Time Low Change	109.83%
All Time Low Date	2009-03-30
ATR	1.31
Beta	0.45
Beta1y	0.32
Beta2y	0.98
Ch YTD	-0.94
High	28.18
High52	66.5
High52 Date	2025-05-28
High52ch	-58.92%
Low	26.56
Low52	14.83
Low52 Date	2026-02-26
Low52ch	84.22%
Ma50ch	35.81%
Price vs 200-day SMA	-6.01%
RSI	78.26
RSI Monthly	34.07
RSI Weekly	51.48
Sharpe ratio	-0.76x
Sortino ratio	-0.89
Total Return	0.14%
Tr YTD	-0.94
Tr15y	0.86%
Tr1m	55.58%
Tr1w	8.41%
Tr3m	6.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 154.3M
Operating Income Growth	-27.53
Operating Income Growth Q	-84.74
Operating Income Growth3 Y	-3.77
Operating Income Growth5 Y	3.23
Operating margin	6.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32,048,659%
Net Borrowing	464,122,000
Shares Insiders	4.42%
Shares Institutions	70.19%
Shares Out	34,540,000
Shares Qo Q	0%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -439M
Average Volume	332,856.6x
Bv Per Share	40.59
CAPEX	EUR -692.6M
Ch10y	-58.19
Ch15y	-16.95
Ch1m	55.58
Ch1w	8.41
Ch1y	-53.85
Ch3m	6.47
Ch3y	-72.14
Ch5y	-69.88
Ch6m	13.74
Change	2.78%
Change From Open	2.86
Close	26.58
Days Gap	-0.08
Depreciation Amortization	230,675,000
Dollar Volume	9,137,037.4
Earnings Date	2026-04-16
EBIT	EUR 154.3M
EBITDA	EUR 385M
EPS	EUR 0.68
F Score	5
FCF	EUR -439M
FCF EV Yield	-14.01x
FCF Per Share	EUR -12.71
Financing CF	463,086,000
Fiscal Year End	November
Founded	1,864
Graham Number	25.07528
Graham Upside	-8.22
Income Tax	EUR 9.9M
Investing CF	-671,265,000
Is Primary Listing	1
Last Earnings Date	2026-04-16
Last Report Date	2025-08-31
Lynch Fair Value	EUR 3.38
Lynch Upside	-87.63
Ma150	24.32
Ma150ch	12.34%
Ma20	22.45
Ma20ch	21.68%
Net CF	34,701,000
Next Earnings Date	2026-07-14
Open	26.56
P OCF Ratio	3.72
Payment Date	2025-06-10
Position In Range	46.91
Ppne	1,815,121,000
Price Date	2026-05-08
Price EBITDA	EUR 2.45
Relative Volume	1x
Revenue	2,250,264,000x
Tax By Revenue	0.44x
Tax Rate	27.4%
Tr6m	13.74%
Volume	334,445
Z Score	1.23

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/GXI dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.04 annual per share

Payout ratio

+0.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-49.4%

0 consecutive years of growth

Total shareholder yield

+0.1%

Next ex-dividend date: 2025-06-06

Performance

ETR/GXI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/GXI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+70.2%

Share of float held by funds and institutions

Insider ownership

+4.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

ETR/GXI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.3

Above 70: short-term overbought

Price vs 200-day MA

-6.0%

50/200-day relationship not available

Beta (5Y)

0.45

Less volatile than the market

Sharpe ratio

-0.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/GXI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/GXI stock rating?

etr/GXI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/GXI analysis?

The full report lives at /stocks/etr/GXI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/GXI?

The latest report frames etr/GXI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/GXI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.